Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?

Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal cancers with a dismal prognosis for the patient. This is due to limited diagnostic options for the early detection of the disease as well as its rather aggressive nature. Despite major advances in oncologic research in general, the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Nollmann, Friederike Inga, Ruess, Dietrich Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459579/
https://www.ncbi.nlm.nih.gov/pubmed/32796566
http://dx.doi.org/10.3390/biomedicines8080281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459579/
https://www.ncbi.nlm.nih.gov/pubmed/32796566
http://dx.doi.org/10.3390/biomedicines8080281

Ejemplares similares